EUVIMEDEUVIMED entdecken
Crossref

Clinical Research on the Combination Therapy of Cancer Attacking and Pain Relieving Powder and Thermal Therapy for Bone Metastasis Cancer Pain

Ying Huang, Chao Liu, Jie Cao, Aiyun Huang, Chengchen Wang

Advances in Engineering Technology Research · 20.03.2026 · 16 (1) · 127

DOI: 10.56028/aetr.16.1.127.2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Engineering Technology Research, online erschienen am 20.03.2026. Verfasst von Ying Huang und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the most common complications of bone-metastatic carcinoma is severe pain that markedly impairs sleep, nutrition, and activities of daily living. To address this, we propose the concomitant use of the topical Chinese herbal formula Gong-ai Zhen-tong San (GZS) and radiofrequency hyperthermia. Sixty consecutive patients with painful bone metastases who attended Chongqing University Cancer Hospital between August 2023 and July 2024 were randomly assigned to either a control group (n = 30) or an experimental group (n = 30). The control group received oral oxycodone/paracetamol (Tylox) for analgesia, whereas the experimental group received the same pharmacologic regimen supplemented with GZS applied externally to the painful site plus radiofrequency hyperthermia. Outcomes were assessed before and after treatment and included the numeric rating scale (NRS) for pain, frequency of breakthrough pain episodes, daily Tylox consumption, Karnofsky Performance Status (KPS), and scores on the pain interference scale; adverse events were also documented. Compared with the control group, the experimental group demonstrated significantly superior improvements in NRS scores, breakthrough pain frequency, Tylox consumption, KPS, and pain interference (all P < 0.05). The incidence of adverse reactions was also lower in the experimental group (P < 0.05). In conclusion, the combination of GZS and radiofrequency hyperthermia effectively alleviates cancer-induced bone pain, enhances quality of life, and exhibits a favorable safety profile, warranting broader clinical implementation.

Zitieren

APA

Huang, Y., Liu, C., Cao, J., Huang, A., & Wang, C. (2026). Clinical Research on the Combination Therapy of Cancer Attacking and Pain Relieving Powder and Thermal Therapy for Bone Metastasis Cancer Pain. Advances in Engineering Technology Research, 16(1), 127. https://doi.org/10.56028/aetr.16.1.127.2026

Vancouver

Huang Y, Liu C, Cao J, Huang A, Wang C. Clinical Research on the Combination Therapy of Cancer Attacking and Pain Relieving Powder and Thermal Therapy for Bone Metastasis Cancer Pain. Advances in Engineering Technology Research. 2026;16(1):127. doi:10.56028/aetr.16.1.127.2026

BibTeX
@article{Huang2026,
  author = {Huang, Ying and Liu, Chao and Cao, Jie and Huang, Aiyun and Wang, Chengchen},
  title = {Clinical Research on the Combination Therapy of Cancer Attacking and Pain Relieving Powder and Thermal Therapy for Bone Metastasis Cancer Pain},
  journal = {Advances in Engineering Technology Research},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {127},
  doi = {10.56028/aetr.16.1.127.2026}
}
Kostenlos starten →